Abstract

Hyperlipidemic or elevated cholesterol levels in the bloodstream is a risk factor for coronary heart disease, which is the leading cause of death in the world. Yoghurt is fermented milk containing lactic acid bacteria that can lower cholesterol and trigliserida level. Goat milk is milk that has advantages easily digested because it has a smaller globule size and has a therapeutic value and is hypoallergenic, so safe to be consumed by everyone.  To determine the effect of giving goat milk yoghurt with Lactobacillus acidophilus and Bifidobacterium to lipid fraction levels in hyperlipidemic white rats. The pure research experience using Pre-test - Post-Test With Control Group Design with 30 samples induced-hyperlipidemic Sprague Dawley rats consisting of 5 treatment groups, include negative control group, positive control group, simvastatin group (dose 0.18 mg/200 gram BB), treatment 1 group (dose 2.7 ml / 200 gram BB) and treatment 2 group (dose 5.4 ml/200 gram BB). The data obtained were treatment descriptively and statistically presented in the form of tables and graphs. Goat milk yoghurt with Lactobacillus acidophilus and Bifidobacterium bacteria with a dose of 2.7 ml / 200 gram BB/ day; doses of 5.4 ml/200 gram BB/day; and simvastatin drugs may lower lipid fraction levels with a median percentage of successively showing Cholesterol results 41,24%, 53,65% and 47,92%, Triglycerides 59,75%, 56,39% and 60,52%, HDL yields 56.67%, 65.70% and 69.79%, LDL 66.46%, 54.24% and 72.02%. The results of data analysis in statistics using One Way ANOVA showed that there was a difference of lipid fraction level in each treatment group significantly (p<0.05). There is an effect of giving goat milk yoghurt with Lactobacillus acidophilus and Bifidobacterium on lipid fraction levels in white rats.

There is no Figure or data content available for this article

References NOT AVAILABLE

How to Cite This

Article Metrics

Download Statistics

Downloads

Download data is not yet available.

Other Statistics

Copyright and Permissions

Publishing your paper with Jurnal Teknologi Kesehatan (Jurtekkes) means that the author or authors retain the copyright in the paper. Jurtekkes granted an exclusive reuse license by the author(s), but the author(s) are able to put the paper onto a website, distribute it to colleagues, give it to students, use it in your thesis etc, even commercially. The author(s) can reuse the figures and tables and other information contained in their paper published by Jurtekkes in future papers or work without having to ask anyone for permission, provided that the figures, tables or other information that is included in the new paper or work properly references the published paper as the source of the figures, tables or other information, and the new paper or work is not direct at private monetary gain or commercial advantage.

Jurtekkes journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. This journal is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets others remix, transform, and build upon the material for any purpose, even commercially.

Jurtekkes journal Open Access articles are distributed under this Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA). Articles can be read and shared for All purposes under the following conditions:

• BY: You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
• SA:  If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.

Data Availability